Related Experiment Video
Updated: Jun 22, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Novel Biginelli dihydropyrimidines with potential anticancer activity: a parallel synthesis and CoMSIA study
B R Prashantha Kumar1, Gopu Sankar, R B Nasir Baig
1Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Ootacamund 643 001, Tamilnadu, India. prashantha@jsscpooty.org
Abstract:
Novel Biginelli dihydropyrimidines of biological interest were prepared using p-toluene sulphonic acid as an efficient catalyst. All the thirty-two synthesised dihydropyrimidines were evaluated for their in vitro antioxidant activity using DPPH method. Only, compounds 28 and 29 exhibited reasonably good antioxidant activity. Furthermore, the synthesised Biginelli compounds were subjected for their in vitro anticancer activity against MCF-7 human breast cancer cells. The title compounds were tested at the concentration of 10 microg. Compounds exhibited activity ranging from weak to moderate and, from moderate to high in terms of percentage cytotoxicity. Among them, compounds 10 and 11 exhibited significant anticancer activity. In order to elucidate the three-dimensional structure-activity relationships (3D QSAR) towards their anticancer activity, we subjected them for comparative molecular similarity indices analysis (CoMSIA). Illustration regarding their synthesis, analysis, antioxidant activity, anticancer activity and 3D QSAR study is described.
Related Concept Videos
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules
